A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

被引：0
|
作者：
Midori Nakagaki
Michael Barras
Cameron Curley
Jason P. Butler
Glen A. Kennedy
机构：
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department, Level 1 Ned Hanlon Building
[2] The University of Queensland,Bone Marrow Transplant Unit, Level 5 Joyce Tweddell Building
[3] Royal Brisbane and Women’s Hospital,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Stem cell transplantation; Antiemetics; Ondansetron; Palonosetron; Olanzapine; Nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [21] Palonosetron vs ondansetron: Prevention of chemotherapy-induced nausea and vomiting in pediatric patients in a multicycle study
    Kabickova, Edita
    Wachtel, Antonio
    Basharova, Elena
    Spinelli, Tulla
    Nicolas, Pierre
    Kovacs, Gabor
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Autologous Hematopoietic Cell Transplant
    Nerone, Theresa A.
    Carlstrom, Kelley D.
    Weber, Catherine
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S117 - S117
  • [23] Olanzapine versus Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting: A Randomized Phase III Trial
    Navari, R.
    Gray, S.
    Kerr, A.
    PSYCHO-ONCOLOGY, 2012, 21 : 111 - 112
  • [24] Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
    Fujiwara, Satoe
    Terai, Yoshito
    Tsunetoh, Satoshi
    Sasaki, Hiroshi
    Kanemura, Masanori
    Ohmichi, Masahide
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (04) : 311 - 319
  • [25] Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Patients Receiving High-Dose Chemotherapy for Autologous Hematopoietic Stem Cell Transplantation (ASCT)
    Hefler, Jade L.
    Ekinci, Ekim
    Cox, James
    Ensor, Joe E.
    McLean, Edward T.
    Ramos, Carlos A.
    Lulla, Premal
    Kamble, Rammurti T.
    Carrum, George
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] A MULTI-CYCLE PHASE III STUDY EVALUATING PALONOSETRON VERSUS ONDANSETRON AT PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PEDIATRIC PATIENTS RECEIVING
    Kovacs, G.
    Wachtel, A.
    Basharova, E.
    Spinelli, T.
    Nicolas, P.
    Kabickova, E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S167 - S167
  • [27] Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
    Meiri, Eyal
    Jhangiani, Haresh
    Vredenburgh, James J.
    Barbato, Luigi M.
    Carter, Frederick J.
    Yang, Hwa-Ming
    Baranowski, Vickie
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (03) : 533 - 543
  • [28] Evaluation of aprepitant for treatment of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing autologous stem cell transplantation.
    Barnett, CM
    Oholendt, MS
    Popat, U
    Carrum, G
    Heslop, HE
    BLOOD, 2004, 104 (11) : 343B - 343B
  • [29] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Lee Schwartzberg
    Sally Y. Barbour
    Gary R. Morrow
    Gianluca Ballinari
    Michael D. Thorn
    David Cox
    Supportive Care in Cancer, 2014, 22 : 469 - 477
  • [30] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Schwartzberg, Lee
    Barbour, Sally Y.
    Morrow, Gary R.
    Ballinari, Gianluca
    Thorn, Michael D.
    Cox, David
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 469 - 477
12345